Article Details
Retrieved on: 2021-12-01 20:11:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Tecentriq is Roche's leading immuno-oncology drug for multiple indications. The same is approved in the European Union and the United States for ...
Article found on: www.entrepreneur.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here